Marketing Medicine Research Analyst 
The Pharma Data
AUGUST 20, 2020
The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. Virtual Event. DEVELOP A UNIFIED SCIENTIFIC VOICE.
Roots Analysis
SEPTEMBER 4, 2024
Roots Analysis has conducted an exhaustive study on In Vitro Diagnostics Market featuring the current market landscape and future opportunity for the companies engaged in offering in vitro diagnostic solutions, over a span of 11 years. The figure pasted below shows a summarized representation of SWOT points affiliated with IVD Market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 27, 2023
In 2019, Cablivi became the first FDA-approved , nanobody-based medicine for acquired thrombotic thrombocytopenic purpura (aTTP), an ultra-orphan condition that causes blood clots in small blood vessels around the body. The disorder has a reported annual incidence between 1.5 cases per million in Europe.
The Pharma Data
DECEMBER 31, 2020
Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
Roots Analysis
AUGUST 12, 2024
Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine. It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market.
Roots Analysis
JANUARY 23, 2024
The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.
The Pharma Data
DECEMBER 28, 2020
Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. in its healthcare practice and conducted postdoctoral research in diabetes-related drug development at Boston University’s School of Medicine.
Expert insights. Personalized for you.
52 
Let's personalize your content